13 Result(s)

Article

Dopexamine in congestive heart failure: how do the pharmacological activities translate into the clinical situation?

Dopexamine is a newly developed sympathetic catecholamine which combines dopaminergic (DA-1) andβ ₂-adrenergic agonist activity with only minorβ ₁-adrenergic action...

T. Meinertz, H. Drexler, Hj. Just in Basic Research in Cardiology (1989)

Article

Clinical relevance of long-term therapy with levodopa and orally active dopamine analogues in patients with chronic congestive heart failure

Beneficial effects of long-term treatment with dopamine analogues in patients with congestive heart failure may result from their vasodilating properties, in particular from renal artery vasodilation. Oral app...

Gerd Hasenfuss, Hj. Just in Basic Research in Cardiology (1989)

Article

Separation between vasodilation and positive inotropism by assessment of myocardial energetics in patients with dilated cardiomyopathy

Phosphodiesterase inhibitors have vasodilating and positive inotropic properties, and these compounds may have energy saving effects due to vasodilation and energy consuming effects due to inotropism. In order...

Ch. Holubarsch, G. Hasenfuss, M. Allgeier, H. W. Heiss… in Basic Research in Cardiology (1989)

Article

Preface

Hj. Just, Ch. Holubarsch, H. Scholz in Basic Research in Cardiology (1989)

Article

Influence of isoproterenol on myocardial energetics. Experimental and clinical investigations

The influence of isoproterenol on myocardial performance and energetics was investigated in normal guinea pig myocardium and in patients with normal left ventricular function.

G. Hasenfuss, C. Holubarsch, E. M. Blanchard, L. A. Mulieri… in Basic Research in Cardiology (1989)

Article

Influence of the calcium-sensitizer UDCG-115 on hemodynamics and myocardial energetics in patients with idiopathic dilated cardiomyopathy. Comparison with nitroprusside

UDCG-115 is a new cardiotonic agent which in vitro increases the sensitivity of the contractile proteins to calcium ions, inhibits the activity of phosphodiesterase, and prolongs the duration of the action pot...

G. Hasenfuss M.D., C. Holubarsch, H. W. Heiss, B. Rattert… in Basic Research in Cardiology (1989)

Chapter and Conference Paper

Influence of isoproterenol on myocardial energetics. Experimental and clinical investigations

The influence of isoproterenol on myocardial performance and energetics was investigated in normal guinea pig myocardium and in patients with normal left ventricular function.

Gerd Hasenfuss, C. Holubarsch… in Inotropic Stimulation and Myocardial Energ… (1989)

Chapter and Conference Paper

Influence of the calcium-sensitizer UDCG-115 on hemodynamics and myocardial energetics in patients with idiopathic dilated cardiomyopathy. Comparison with nitroprusside

UDCG-115 is a new cardiotonic agent which in vitro increases the sensitivity of the contractile proteins to calcium ions, inhibits the activity of phosphodiesterase, and prolongs the duration of the action pot...

Gerd Hasenfuss M.D., C. Holubarsch… in Inotropic Stimulation and Myocardial Energ… (1989)

Chapter and Conference Paper

Dopexamine in congestive heart failure: how do the pharmacological activities translate into the clinical situation?

Dopexamine is a newly developed sympathetic catecholamine which combines dopaminergic (DA-1) and β ₂-adrenergic agonist activity with only minor β ₁-adrenergic action. Thereby, this co...

Prof. Dr. T. Meinertz, H. Drexler, Hj. Just in Inotropic Stimulation and Myocardial Energ… (1989)

Chapter and Conference Paper

Clinical relevance of long-term therapy with levodopa and orally active dopamine analogues in patients with chronic congestive heart failure

Beneficial effects of long-term treatment with dopamine analogues in patients with congestive heart failure may result from their vasodilating properties, in particular from renal artery vasodilation. Oral app...

Gerd Hasenfuss, Hj. Just in Inotropic Stimulation and Myocardial Energetics (1989)

Chapter and Conference Paper

Separation between vasodilation and positive inotropism by assessment of myocardial energetics in patients with dilated cardiomyopathy

Phosphodiesterase inhibitors have vasodilating and positive inotropic properties, and these compounds may have energy saving effects due to vasodilation and energy consuming effects due to inotropism. In order...

PD Dr. Ch. Holubarsch, G. Hasenfuss… in Inotropic Stimulation and Myocardial Energ… (1989)